Cancer Action Events

Share

Test Tubes

The Future of Cancer Care: The Role of Innovation in Connecticut

Thursday, September 20, 2018 - 8:00am to 10:00am
Pond House Cafe
1555 Asylum Ave
West Hartford, CT 06117
RSVP

The American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society, is the nation’s leading cancer advocacy organization working every day to make cancer issues a top priority.  ACS CAN unites and empowers cancer patients, survivors, caregivers, and their loved ones, giving them the training and tools they need to be heard.  ACS CAN’s public policy priorities are focused on the actions that elected leaders at all levels of government can take to accelerate the ability to save lives and win the fight against cancer.

ACS CAN is hosting our 3rd annual Connecticut public policy forum on September 20, 2018 at the Pond House Cafe in West Hartford.  The goal is to create a dialogue for leaders in business, health care, academia, public policy, patient advocacy, as well as other stakeholders to analyze and discuss how Connecticut can best position itself to take advantage of the remarkable pace of technological innovation in cancer care, including that being developed right here in CT.

Focus of the forum

This event will examine the current impact of innovation on cancer research, diagnosis and treatment and discuss advancements and barriers to new technological discoveries. Participants include key stakeholders throughout the oncology community, including leaders in business, academia, public policy, health care systems, provider groups, advocacy, and others.  ACS CAN will use this event to help illustrate and explore the following questions:

  • Current technological applications that are changing traditional methods of diagnosis, treatment and delivery of health care in the Connecticut;
  • How does geography impact access to innovation and how can disparities be addressed moving forward?
  • The “real” impact these technologies will have on the quality, delivery and patient experience of care;
  • Drug development and Insurance coverage;
  • Key policy barriers around the development and adoption of technologies across the care continuum and potential solutions needed to overcome them; and,
  • The future direction of technological innovation in the fight against cancer.

Panelists:

Michael Poe, PhD–  American Cancer Society funded researcher and Postdoctoral Fellow at the University of Connecticut 

Thomas Lechner, PhD– Therapeutic Area Head Oncology for Boehringer Ingelheim Pharmaceuticals, Inc.

Mark Schaefer, PhD - Director, Healthcare Innovation at Connecticut Office of the Healthcare Advocate

Omar Eton, MD – Medical Director, Hartford Healthcare Cancer Institute, Melanoma & Skin Cancer Center and Phase I Clinical Trials Unit

Anne C. Chiang, MD, PhD – Associate Professor of Medicine, Yale Cancer Center; Chief Network Officer, Smilow Cancer Network; Deputy Chief Medical Officer, Smilow Cancer Hospital

Moderator: 

Susan Raff – Chief Capitol Reporter and co-host of Face the State, WFSB CT Eyewitness News

 

We would like to thank our Sponsors:

Gold Sponsor:

abbvie

 

 

 

Silver Sponsors:

Bristol-Myers Squibb

GlaxoSmithKline

Boehringer Ingelheim

 

Please contact Natalie Shurtleff at [email protected] for more information regarding sponsorship opportunities.